Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chengxin Liu
Institutions:
Hunan University of Traditional Chinese Medicine,
Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Observed institutions:
Hunan University of Traditional Chinese Medicine,
First Affiliated Hospital of Hunan University of Traditional Chinese Medicine,
Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine
ORCID:
0009-0003-9011-2048
Observed ORCID:
0009-0003-9011-2048
OpenAlex ID:
A5103155325
Network and Experimental Pharmacology on Mechanism of Yixintai Regulates the TMAO/PKC/NF-κB Signaling Pathway in Treating Heart Failure
2024
·
Ziyan Wang
, Chengxin Liu
, et al.
·
Drug Design Development and Therapy
·
17
PDF
Integrating bioinformatics and ferroptosis to reveal the protective mechanism of Astragaloside IV on chronic heart failure rats
2024
·
Hui Yuan
, Min Shi
, et al.
·
Scientific Reports
·
11
Study on the Anti-Atherosclerotic Mechanisms of Xin-Tong-Tai Granule Through Network Pharmacology, Molecular Docking, and Experimental Validation
2024
·
Junping Zhu
, Ziyan Wang
, et al.
·
Journal of Inflammation Research
·
3
Yixintai treats chronic heart failure in rats by regulating gut microbiota and bile acid
2025
·
Min Shi
, Hui Yuan
, et al.
·
Frontiers in Microbiology
·
2
PDF
Yixintai granules enhance glucose and lipid metabolism after ischemic heart failure by regulating inflammatory factors via the LPS/TLR4/NF-κB signaling pathway
2026
·
Ziyan Wang
, Chengxin Liu
, et al.
·
Frontiers in Immunology
PDF
Show more works
View as search
Works count:
5
Citation count:
33
H-index:
3
I10-index:
2
Year
Topic
Type